PREVALENCE AND TREATMENT OF HYPERTENSIVES COMORBID WITH TYPE 2 DIABETES MELLITUS IN A NIGERIAN PRIVATE HOSPITAL
DOI:
https://doi.org/10.53555/nnpbs.v8i11.1418Keywords:
Comorbidity, Diabetes mellitus, Hypertension, PrevalenceAbstract
The coexistence of hypertension and diabetes accelerates the related complications and increases morbidities and mortalities.
The study investigated the prevalence and treatment of comorbid hypertension and diabetes in a private hospital.
References
Long AN, Dagogo?Jack S. Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. The journal of clinical hypertension, 2011; 13(4), 244-251.
Alloubani A, Saleh A, Abdelhafiz I. Hypertension and diabetes mellitus as a predictive risk factors for stroke. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2018; 12(4), 577-584.
Gutierrez J, Alloubani A, Mari M, Alzaatreh M. Cardiovascular disease risk factors: hypertension, diabetes mellitus and obesity among Tabuk citizens in Saudi Arabia. The open cardiovascular medicine journal, 2018; 12, 41.
Sunkara N, Ahsan CH. Hypertension in diabetes and the risk of cardiovascular disease. Cardiovascular endocrinology, 2017; 6(1), 33.
Yu HM, Liu GZ. Relationship between hypertension, diabetes mellitus, and cardiovascular disease. Mol Cardiol China, 2004; 4(1), 52-5
Eren NK, Harman E, Dolek D, Levent F. Rate of blood pressure control and antihypertensive treatment approaches in diabetic patients with hypertension. Arch Turk Soc Cardiol, 2014; 42(8), 733-740.
Wang, Z., Yang, T. & Fu, H. Prevalence of diabetes and hypertension and their interaction effects on cardio-cerebrovascular diseases: a cross-sectional study. BMC Public Health 2021; 21, 1224. https://doi.org/10.1186/s12889-021-11122-y.
Yu HM, Liu GZ. Relationship between hypertension, diabetes mellitus, and cardiovascular disease. Mol Cardiol China. 2004;4(1):52–5.
Wittchen HU, Krause P, Höfler M, et al. Diabetes mellitus und assoziierte Erkrankungen in der Allgemeinarztpraxis. Grössenordnung und Indikatoren der Belastung und der Versorgungsqualität [Hypertension, diabetes mellitus and comorbidity in primary care]. Fortschr Med Orig. 2003;121(Suppl 1):19–27.
Okosun IS, Chandra KM, Choi S, et al. Hypertension and type 2 diabetes comorbidity in adults in the United States: risk of overall and regional adiposity. Obes Res. 2001; 9(1):1–9.
Channanath AM, Farran B, Behbehani K, et al. State of diabetes, hypertension, and comorbidity in Kuwait: showcasing the trends as seen in native versus expatriate populations. Diab Care. 2013; 36(6): e75.
Hu G, Jousilahti P, Tuomilehto J. Joint effects of a history of hypertension at baseline and type 2 diabetes at baseline and during follow-up on the risk of coronary heart disease. Eur Heart J. 2007;28(24):3059–66.
Zafari N, Asgari S, Lotfaliany M, et al. Impact of Hypertension versus Diabetes on Cardiovascular and All-cause Mortality in Iranian Older Adults: Results of 14 Years of Follow-up. Sci Rep. 2017;7(1):14220.
Hu G, Sarti C, Jousilahti P’et al. The impact of a history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality. Stroke. 2005;36(12):2538–43.
Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high?risk patients. N Engl J Med. 2008; 359:2417.
Patel A, ADVANCE Collaborative Group, MacMahon S, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370:829.
Patel A & ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macro vascular and micro vascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. The Lancet, 2007, 370(9590), 829-840.
Diabetes Prevention Research Group . Impact of intensive lifestyle and metformin on cardiovascular risk factors in the diabetes prevention program (DPP). Diabetes Care. 2005;28(4):888–894.
Khaw KT, Wareham N, Bingham S, et al. Association of hemoglobin A1C with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004;141:413.
Ranney L, Melvin C, Lux L, et al. Systematic review: smoking cessation intervention strategies for adults and adults in special populations. Ann Intern Med. 2006;145:845–856.
Katzmarzyk PT, Church TS, Blair SN. Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men. Archives of internal medicine, 2004; 164(10), 1092-1097.
Ranney L, Melvin C, Lux L, McClain E, Lohr KN. Systematic review: smoking cessation intervention strategies for adults and adults in special populations. Annals of internal medicine, 2006; 145(11), 845-856.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Journal of Advance Research in Pharmacy & Biological Science
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Terms & Condition
Submission -
Author can submit the manuscript through our online submission process or email us at the designated email id in contact details.
The other mode of submission not accepted than online and email.
Before submission please read the submission guidelines.
NN Publication accepts only article submitted in pdf/doc/docx/rtf file format. Another format except given file formats will no be considered .
Author will be responsible for the error mistakes in the submission files. The minor changes can be done without any cost after publication. But for major changes NN Publication may charges you the editing charges.
Publication (Online) -
The online publication is scheduled on last date of every month, but it can be delayed by 24 to 48 hours due to editorial process if huge number of articles comes to publish in single issue.
Automatic notificatation email will be sent to the all users on publication of an issue, so its author’s duty to check their email inbox or SPAM folder to get this notification.
After publication of article author can not withdraw their article.
If editor’s found any issue after publication of article then the NN Publication have the authority to remove the article from online website.
No refund will be provided after online publication of article.
Publication (Print) -
The print copy publication are sent as per the author’s request after 2 weeks of online publication of that issue.
NN Publication will ship the article by India Post and provide the consignment number on dispatch of print copy.
NN Publication follows all the guidelines of delivery provided by IndiaPost and hence not responsible for delay in delivery due to any kind of reasons.
Refund of hard copy will not be provided after dispatch or print of the journal.
NN Publication will be responsible for raise a complain if there is any issue occurs in delivery, but still will not be responsible for providing the refund.
NN Publication will be responsible to resend the print copy only and only if the print copy is lost or print copy is damaged in delivery / or there is delay more than 6 months.
According to India Post the delivery should be completed with in 1-3 weeks after dispatch of articles.
Privacy Policy-
NN Publication uses the email ids of authors and editors and readers for sending editorial or publication notification only, we do not reveal or sell the email ids to any other website or company.
